BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 35316102)

  • 1. Clinical characteristics and long-term outcomes in patients with mixed Class III/IV + V and pure proliferative lupus nephritis: A single-center experience.
    Ahn SS; Yoo J; Lee SW; Song JJ; Park YB; Jung SM
    Lupus; 2022 Apr; 31(5):588-595. PubMed ID: 35316102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of early renal biopsy in systemic lupus erythematosus patients presenting with renal involvement.
    Hsieh YP; Wen YK; Chen ML
    Clin Nephrol; 2012 Jan; 77(1):18-24. PubMed ID: 22185964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.
    Romick-Rosendale LE; Brunner HI; Bennett MR; Mina R; Nelson S; Petri M; Kiani A; Devarajan P; Kennedy MA
    Arthritis Res Ther; 2011; 13(6):R199. PubMed ID: 22152586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal biopsy findings in new-onset systemic lupus erythematosus with clinical renal disease.
    Wen YK
    Int Urol Nephrol; 2011 Sep; 43(3):801-6. PubMed ID: 21336956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal outcomes in mixed proliferative and membranous lupus nephritis (Class III/IV + V): A long-term observational study.
    Ikeuchi H; Hiromura K; Kayakabe K; Tshilela KA; Uchiyama K; Hamatani H; Sakairi T; Kaneko Y; Maeshima A; Nojima Y
    Mod Rheumatol; 2016 Nov; 26(6):908-913. PubMed ID: 27115200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
    Srivastava P; Abujam B; Misra R; Lawrence A; Agarwal V; Aggarwal A
    Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term renal survival of paediatric patients with lupus nephritis.
    Demir S; Gülhan B; Özen S; Çeleğen K; Batu ED; Taş N; Orhan D; Bilginer Y; Düzova A; Ozaltin F; Topaloğlu R
    Nephrol Dial Transplant; 2022 May; 37(6):1069-1077. PubMed ID: 33826705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience.
    Duran E; Yıldırım T; Taghiyeva A; Bilgin E; Arıcı M; Sağlam EA; Özen S; Üner M; Erdem Y; Kalyoncu U; Ertenli AI
    Lupus; 2022 Aug; 31(9):1147-1156. PubMed ID: 35658643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis.
    Kwon OC; Park JH; Lee SW; Song JJ; Park YB; Park MC
    Yonsei Med J; 2020 Nov; 61(11):951-957. PubMed ID: 33107238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression.
    Mahajan A; Amelio J; Gairy K; Kaur G; Levy RA; Roth D; Bass D
    Lupus; 2020 Aug; 29(9):1011-1020. PubMed ID: 32571142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis.
    Kwon OC; Park JH; Park HC; Jung SM; Lee SW; Song JJ; Park YB; Park MC
    Arthritis Res Ther; 2020 Jun; 22(1):138. PubMed ID: 32517774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clinical and laboratory characteristics and pathology of lupus nephritis-based on 710 renal biopsies in China.
    Song K; Liu X; Liu J; Yin Z; Chen P; Cai G; Chen X
    Clin Rheumatol; 2020 Nov; 39(11):3353-3363. PubMed ID: 32435895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes in refractory lupus nephritis: Data from an observational study.
    Gururani S; Devarasetti PK; Uppin M; Rajasekhar L
    Lupus; 2021 Oct; 30(11):1725-1731. PubMed ID: 34304627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of Proteinuria and Renal Pathology in Systemic Lupus Erythematosus Patients.
    Al Arfaj AS; Khalil N
    Saudi J Kidney Dis Transpl; 2023 Mar; 34(2):154-160. PubMed ID: 38146725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Outcomes between Individuals with Pure and Mixed Lupus Nephritis: A Retrospective Study.
    Ilori TO; Enofe N; Oommen A; Cobb J; Navarrete J; Adedinsewo DA; Oshikoya O; Fevrier H; Farris AB; Plantinga L; Ojo AO
    PLoS One; 2016; 11(6):e0157485. PubMed ID: 27304068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological Indexes: Can They Predict Lupus Nephritis Outcomes? A Retrospective Study.
    Navarro D; Ferreira AC; Viana H; Carvalho F; Nolasco F
    Acta Med Port; 2019 Oct; 32(10):635-640. PubMed ID: 31625875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term renal outcomes of patients with non-proliferative lupus nephritis.
    Kang ES; Ahn SM; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    Korean J Intern Med; 2023 Sep; 38(5):769-776. PubMed ID: 37545141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal transplantation in lupus nephritis: a Brazilian cohort.
    Oliveira CS; d Oliveira I; Bacchiega AB; Klumb EM; Albuquerque EM; Souza E; Suassuna JH; Ribeiro FM
    Lupus; 2012 Apr; 21(5):570-4. PubMed ID: 22129601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. History of proliferative glomerulonephritis predicts end stage kidney disease in pure membranous lupus nephritis.
    Fava A; Fenaroli P; Rosenberg A; Bagnasco S; Li J; Monroy-Trujillo J; Fine D; Atta MG; Petri M
    Rheumatology (Oxford); 2022 May; 61(6):2483-2493. PubMed ID: 34664621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.